Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG vs SFICB in Total Hip Arthroplasty
NCT04690023Phase 4
Key facts
- Status
- Unknown
- Start
- Jan 2022
- Primary completion
- Mar 2023
- Countries
- 1
- Sponsor
- University of Liège
- Modality
- Orthosteric Ligands
- Drugs
- ropivacaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain, sponsored by University of Liège. Primary endpoint: Numerical Rating Scale at 6 hours. Status: unknown.
02
Design
- Study design
- Randomized
03
Who it enrols
Adults undergoing elective primary total hip arthroplasty via posterior approach with spinal anesthesia, excluding those with chronic pain, addiction, or serious organ disease.
04
Endpoints
Primary
Numerical Rating Scale
Secondary
6-Minute Walk
Beyond the preview
Go deeper on NCT04690023.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690023.